Time running out
FDA may be last hope for Hudson girl
McKenzie Lowe, 12, of Hudson, pictured here with her beloved horse, Star, and grandfather, Frank LaFountain, has been battling a rare, inoperable brain tumor for the past year. Doctors believe an experimental new drug that's not yet approved by the FDA may be McKenzie's last hope, though minors aren't typically accepted for clinical trials. McKenzie's friends and family are in the process of collecting 100,000 signatures in hopes of convincing President Obama and the FDA to make a "compassion exception" for the Hudson sixth grader. (COURTESY)
McKenzie, the daughter of Ron and Dianne Lowe, initially responded to treatment, however doctors warned that a relapse was likely since statistically the disease has an overall survival rate of nine months.
The good news, doctors said, is that McKenzie is otherwise in good physical condition, and she's been medically cleared for further treatment with an experimental drug known as Antineoplastons (ANP).
According to the National Cancer Institute, a recent ANP study of 10 patients concluded that two of those patients saw their tumors diminish over time. Another three experienced partial tumor shrinkage, while the tumors of another three patients remained, though their conditions stabilized. In two of the study patients, the tumors continued to grow.
"She's an incredible little girl," family friend Kim Frenette said this week. "With the exception of a little hair loss, you'd look at McKenzie and never imagine she's sick."
Since the Lowe family home wasn't equipped to house large animals, Frenette began thinking outside the box.
Stacey Cole's Nature Talks: Turkey vultures not commonly seen in NH until fairly recently
Candidate surveys for Hooksett School Board
Nashua cadet receives Civil Air Patrol award
Funding sought for new DPW facility in Weare